USD 0.2
(-6.42%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -32.36 Million USD | 15.87% |
2022 | -38.26 Million USD | 2.35% |
2021 | -39.18 Million USD | -21.61% |
2020 | -32.22 Million USD | -30.5% |
2019 | -24.69 Million USD | 22.44% |
2018 | -31.83 Million USD | -121.66% |
2017 | -14.36 Million USD | -25.26% |
2016 | -11.46 Million USD | 66.93% |
2015 | -34.67 Million USD | -26.71% |
2014 | -27.36 Million USD | -198.4% |
2013 | -9.17 Million USD | 40.75% |
2012 | -15.47 Million USD | 39.81% |
2011 | -25.71 Million USD | -345.27% |
2010 | 10.48 Million USD | 125.63% |
2009 | -40.91 Million USD | -431.06% |
2008 | -7.7 Million USD | 20.0% |
2007 | -9.62 Million USD | -21.29% |
2006 | -7.93 Million USD | -161.19% |
2005 | -3.03 Million USD | 27.62% |
2004 | -4.19 Million USD | 34.09% |
2003 | -6.37 Million USD | 23.62% |
2002 | -8.34 Million USD | 22.28% |
2001 | -10.73 Million USD | -26.6% |
2000 | -8.47 Million USD | -13.05% |
1999 | -7.5 Million USD | -17.19% |
1998 | -6.4 Million USD | 21.95% |
1997 | -8.2 Million USD | -30.16% |
1996 | -6.3 Million USD | -61.54% |
1995 | -3.9 Million USD | 11.36% |
1994 | -4.4 Million USD | -83.33% |
1993 | -2.4 Million USD | -41.18% |
1992 | -1.7 Million USD | -41.67% |
1991 | -1.2 Million USD | -33.33% |
1990 | -900 Thousand USD | 18.18% |
1989 | -1.1 Million USD | 15.38% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -7.24 Million USD | -7.98% |
2024 Q3 | -6.85 Million USD | 5.36% |
2024 Q1 | -6.7 Million USD | 12.07% |
2023 Q2 | -8.5 Million USD | -1.31% |
2023 Q4 | -7.63 Million USD | 8.8% |
2023 Q3 | -8.36 Million USD | 1.67% |
2023 FY | -32.19 Million USD | 15.87% |
2023 Q1 | -8.39 Million USD | 5.68% |
2022 Q3 | -10.54 Million USD | -4.46% |
2022 Q1 | -8.78 Million USD | -7.04% |
2022 Q2 | -10.09 Million USD | -14.94% |
2022 FY | -38.26 Million USD | 2.35% |
2022 Q4 | -8.9 Million USD | 15.56% |
2021 Q1 | -7.93 Million USD | -43.07% |
2021 Q2 | -11.28 Million USD | -42.14% |
2021 Q3 | -8.93 Million USD | 20.77% |
2021 FY | -39.18 Million USD | -21.61% |
2021 Q4 | -8.2 Million USD | 8.21% |
2020 Q4 | -5.54 Million USD | 45.72% |
2020 FY | -32.22 Million USD | -30.5% |
2020 Q3 | -10.22 Million USD | -13.42% |
2020 Q2 | -9.01 Million USD | -64.59% |
2020 Q1 | -5.47 Million USD | -12.93% |
2019 FY | -24.69 Million USD | 22.44% |
2019 Q1 | 1.24 Million USD | 108.35% |
2019 Q2 | -6.44 Million USD | -617.51% |
2019 Q3 | -12.08 Million USD | -87.43% |
2019 Q4 | -4.84 Million USD | 59.88% |
2018 Q2 | -4.7 Million USD | 23.91% |
2018 Q1 | -6.18 Million USD | -22.66% |
2018 Q3 | -6.01 Million USD | -27.75% |
2018 FY | -31.83 Million USD | -121.66% |
2018 Q4 | -14.92 Million USD | -148.18% |
2017 Q2 | -8.4 Million USD | -337.77% |
2017 FY | -14.36 Million USD | -25.26% |
2017 Q4 | -5.04 Million USD | -13.48% |
2017 Q1 | 3.53 Million USD | 417.45% |
2017 Q3 | -4.44 Million USD | 47.13% |
2016 FY | -11.46 Million USD | 66.93% |
2016 Q1 | 2.34 Million USD | 123.79% |
2016 Q4 | -1.11 Million USD | 71.06% |
2016 Q3 | -3.84 Million USD | 56.48% |
2016 Q2 | -8.84 Million USD | -477.69% |
2015 Q4 | -9.84 Million USD | -122.25% |
2015 FY | -34.67 Million USD | -26.71% |
2015 Q1 | -7.84 Million USD | -8.63% |
2015 Q3 | -4.42 Million USD | 64.73% |
2015 Q2 | -12.55 Million USD | -60.05% |
2014 FY | -27.36 Million USD | -198.4% |
2014 Q2 | -13.36 Million USD | -208.36% |
2014 Q3 | -2.44 Million USD | 81.71% |
2014 Q4 | -7.22 Million USD | -195.43% |
2014 Q1 | -4.33 Million USD | -154.99% |
2013 Q2 | -713.37 Thousand USD | 69.12% |
2013 FY | -9.17 Million USD | 40.75% |
2013 Q4 | -1.69 Million USD | 61.78% |
2013 Q3 | -4.44 Million USD | -523.44% |
2013 Q1 | -2.31 Million USD | 9.99% |
2012 Q1 | -3.58 Million USD | -54.53% |
2012 Q4 | -2.56 Million USD | -207.22% |
2012 Q3 | -835.44 Thousand USD | 90.16% |
2012 Q2 | -8.49 Million USD | -137.18% |
2012 FY | -15.47 Million USD | 39.81% |
2011 Q1 | -6.25 Million USD | -5.98% |
2011 Q4 | -2.31 Million USD | 25.58% |
2011 Q2 | -14.02 Million USD | -124.44% |
2011 FY | -25.71 Million USD | -345.27% |
2011 Q3 | -3.11 Million USD | 77.8% |
2010 Q2 | -2.17 Million USD | -111.36% |
2010 Q1 | 19.15 Million USD | 162.86% |
2010 Q3 | -601.12 Thousand USD | 72.39% |
2010 Q4 | -5.89 Million USD | -881.16% |
2010 FY | 10.48 Million USD | 125.63% |
2009 Q4 | -30.48 Million USD | -363.03% |
2009 Q3 | -6.58 Million USD | -247.43% |
2009 Q2 | -1.89 Million USD | 2.88% |
2009 FY | -40.91 Million USD | -431.06% |
2009 Q1 | -1.95 Million USD | -195.11% |
2008 FY | -7.7 Million USD | 20.0% |
2008 Q4 | -661.1 Thousand USD | 66.77% |
2008 Q1 | -1.84 Million USD | -672.84% |
2008 Q2 | -3.21 Million USD | -74.21% |
2008 Q3 | -1.98 Million USD | 38.03% |
2007 Q1 | -1.11 Million USD | 74.23% |
2007 FY | -9.62 Million USD | -21.29% |
2007 Q4 | -238.43 Thousand USD | 95.71% |
2007 Q3 | -5.55 Million USD | -103.94% |
2007 Q2 | -2.72 Million USD | -144.87% |
2006 Q2 | -1.33 Million USD | -33.49% |
2006 Q1 | -997.12 Thousand USD | -586.93% |
2006 FY | -7.93 Million USD | -161.19% |
2006 Q4 | -4.31 Million USD | -233.6% |
2006 Q3 | -1.29 Million USD | 2.78% |
2005 Q3 | -973.35 Thousand USD | 9.4% |
2005 Q2 | -1.07 Million USD | 10.22% |
2005 Q1 | -1.19 Million USD | -20.3% |
2005 FY | -3.03 Million USD | 27.62% |
2005 Q4 | 204.77 Thousand USD | 121.04% |
2004 Q4 | -994.74 Thousand USD | -11.32% |
2004 Q3 | -893.61 Thousand USD | 25.86% |
2004 Q2 | -1.2 Million USD | -8.97% |
2004 Q1 | -1.1 Million USD | 41.6% |
2004 FY | -4.19 Million USD | 34.09% |
2003 Q2 | -1.03 Million USD | 38.67% |
2003 Q1 | -1.68 Million USD | -22.64% |
2003 Q3 | -1.76 Million USD | -70.76% |
2003 FY | -6.37 Million USD | 23.62% |
2003 Q4 | -1.89 Million USD | -7.45% |
2002 Q1 | -2.88 Million USD | -14.82% |
2002 Q4 | -1.37 Million USD | 35.01% |
2002 Q3 | -2.11 Million USD | -8.96% |
2002 Q2 | -1.93 Million USD | 32.78% |
2002 FY | -8.34 Million USD | 22.28% |
2001 Q4 | -2.51 Million USD | -22.78% |
2001 Q1 | -2.54 Million USD | -45.26% |
2001 Q2 | -3.63 Million USD | -42.87% |
2001 Q3 | -2.04 Million USD | 43.72% |
2001 FY | -10.73 Million USD | -26.6% |
2000 Q2 | -2.85 Million USD | -68.11% |
2000 FY | -8.47 Million USD | -13.05% |
2000 Q1 | -1.7 Million USD | 22.73% |
2000 Q4 | -1.75 Million USD | 19.12% |
2000 Q3 | -2.16 Million USD | 24.24% |
1999 Q2 | -2.1 Million USD | -40.0% |
1999 Q3 | -1.7 Million USD | 19.05% |
1999 Q4 | -2.2 Million USD | -29.41% |
1999 FY | -7.5 Million USD | -17.19% |
1999 Q1 | -1.5 Million USD | 21.05% |
1998 FY | -6.4 Million USD | 21.95% |
1998 Q1 | -1.6 Million USD | 11.11% |
1998 Q2 | -1.2 Million USD | 25.0% |
1998 Q3 | -1.6 Million USD | -33.33% |
1998 Q4 | -1.9 Million USD | -18.75% |
1997 Q4 | -1.8 Million USD | 5.26% |
1997 Q2 | -3.6 Million USD | -200.0% |
1997 Q3 | -1.9 Million USD | 47.22% |
1997 FY | -8.2 Million USD | -30.16% |
1997 Q1 | -1.2 Million USD | 33.33% |
1996 Q3 | -1.5 Million USD | 50.0% |
1996 Q1 | -1.8 Million USD | -80.0% |
1996 FY | -6.3 Million USD | -61.54% |
1996 Q4 | -1.8 Million USD | -20.0% |
1996 Q2 | -3 Million USD | -66.67% |
1995 Q3 | -800 Thousand USD | 20.0% |
1995 Q1 | -1.1 Million USD | 8.33% |
1995 Q2 | -1 Million USD | 9.09% |
1995 Q4 | -1 Million USD | -25.0% |
1995 FY | -3.9 Million USD | 11.36% |
1994 Q2 | -1.1 Million USD | -37.5% |
1994 Q3 | -1.3 Million USD | -18.18% |
1994 Q4 | -1.2 Million USD | 7.69% |
1994 FY | -4.4 Million USD | -83.33% |
1994 Q1 | -800 Thousand USD | 11.11% |
1993 Q1 | -400 Thousand USD | 55.56% |
1993 Q4 | -900 Thousand USD | -50.0% |
1993 Q2 | -500 Thousand USD | -25.0% |
1993 FY | -2.4 Million USD | -41.18% |
1993 Q3 | -600 Thousand USD | -20.0% |
1992 Q4 | -900 Thousand USD | -350.0% |
1992 Q1 | -300 Thousand USD | 50.0% |
1992 Q2 | -300 Thousand USD | 0.0% |
1992 FY | -1.7 Million USD | -41.67% |
1992 Q3 | -200 Thousand USD | 33.33% |
1991 Q2 | -200 Thousand USD | 0.0% |
1991 Q3 | -200 Thousand USD | 0.0% |
1991 Q4 | -600 Thousand USD | -200.0% |
1991 Q1 | -200 Thousand USD | 50.0% |
1991 FY | -1.2 Million USD | -33.33% |
1990 FY | -900 Thousand USD | 18.18% |
1990 Q4 | -400 Thousand USD | -300.0% |
1990 Q3 | -100 Thousand USD | 50.0% |
1990 Q2 | -200 Thousand USD | 0.0% |
1990 Q1 | -200 Thousand USD | 60.0% |
1989 Q3 | -200 Thousand USD | 0.0% |
1989 Q4 | -500 Thousand USD | -150.0% |
1989 Q2 | - USD | 100.0% |
1989 Q1 | -200 Thousand USD | 0.0% |
1989 FY | -1.1 Million USD | 15.38% |
Name | Net Income | Net Income Difference |
---|---|---|
AIM ImmunoTech Inc. | -28.96 Million USD | -11.753% |
Ampio Pharmaceuticals, Inc. | -8.63 Million USD | -274.952% |
Armata Pharmaceuticals, Inc. | -69.04 Million USD | 53.124% |
Actinium Pharmaceuticals, Inc. | -48.81 Million USD | 33.701% |
Azitra, Inc. | -11.28 Million USD | -186.835% |
Can-Fite BioPharma Ltd. | -7.63 Million USD | -323.97% |
Chromocell Therapeutics Corporation | -7.38 Million USD | -338.515% |
Calidi Biotherapeutics, Inc. | -29.21 Million USD | -10.781% |
iBio, Inc. | -24.9 Million USD | -29.947% |
Lineage Cell Therapeutics, Inc. | -21.48 Million USD | -50.637% |
MAIA Biotechnology, Inc. | -19.77 Million USD | -63.688% |
Matinas BioPharma Holdings, Inc. | -22.94 Million USD | -41.077% |
Navidea Biopharmaceuticals, Inc. | -15.17 Million USD | -113.254% |
NovaBay Pharmaceuticals, Inc. | -9.64 Million USD | -235.745% |
NanoViricides, Inc. | -8.29 Million USD | -290.225% |
Oragenics, Inc. | -20.65 Million USD | -56.692% |
BiomX Inc. | -26.16 Million USD | -23.68% |
BiomX Inc. | -26.16 Million USD | -23.68% |
Protalix BioTherapeutics, Inc. | 8.31 Million USD | 489.387% |
Palatin Technologies, Inc. | -29.73 Million USD | -8.844% |
Scorpius Holdings, Inc. | -45.21 Million USD | 28.421% |
Theriva Biologics, Inc. | -18.34 Million USD | -76.39% |